Unfortunately, a coding error was discovered in the analysis code used for calculating volumetric vascular density (VVD). Specifically, the variable used as the devisor in the VVD calculation was not reinitialized in every iteration during whole batch analysis of the entire data set. This resulted in an error in calculations for most of the VVD growth curves for untreated, local control, and local failure tumors. We have corrected this error and reprocessed the data which was affected. Revised tables and discussion of results are provided here.
(Corrected) Figure 4:
(Corrected) Figure 5:
(Corrected) Figure 6 and Figure 6 Caption: [Vascular density measurements for days 7, 10, 15, and 19 should read 0.48, 0.46, 0.43, and 0.48, respectively.] A visual comparison of vascular density and tumor volume changes during the tumor recurrence phase of a 15 Gy local failure tumor. Measured VVD changes are not found to be significant. However, when looking at a maximum intensity projection of the 3D image, there are visual indications of newly formed vessels at days 15 and 19. The tumor boundary in the b-mode images is indicated by the solid yellow line.
(Corrected) Figure 7:
(Corrected) Table 2:
Table 2.
Untreated | All Treated | 15 Gy | 20 Gy | 25 Gy | ||||
---|---|---|---|---|---|---|---|---|
Local Control | Local Failure | Local Control | Local Failure | Local Control | Local Failure | |||
TV Doubling time - Initial Response (days) | 1.9 ± 0.5 | 3.8 ± 2.6 (p=0.009) |
5.6 ± 3.4 | 3.4 ± 0.5 | 2.4 ± 1.4 | |||
5.5 ± 1.2 | 5.7 ± 4.7 | 3.6 ± 0.7 | 3.3 ± 0.3 | 2.3 ± 1.3 | 2.4 ± 1.9 | |||
VVD increase - Initial Response (%) |
39.1 ± 105.0 | 32.8 ± 39.1 |
33.2 ± 26.9 | 85.6 ± 62.6 | 11.7 ± 21.9 | |||
36.8 ± 47.6 | 31.1 ± 10.9 | 62.2 ± 117.3 | 101.3 ± 7.6 | 17.2 ± 25.9 | 7.0 ± 22.6 | |||
TV Halving time - Regression (days) | ~ | 3.0 ± 1.0 | 3.2 ± 0.7 | 2.8 ± 0.3 | 2.9 ± 1.4 | |||
2.5 ± 0.3 | 3.8 ± 0.5 | 3.0 ± 0.6 | 2.7 ± 0.1 | 2.1 ± 0.3 | 1.3 ± 1.6 | |||
VVD Regression (%) | ~ | -20.4 ± 30.6 | -8.1 ± 33.0 | -49.0 ± 8.6 | --13.3 ± 27.8 | |||
-25.2 ± 28.0 | -1.3 ± 35.1 | -55.0 ± 9.1 | -45.0 ± 6.8 | --15.2 ± 26.6 | --10.2 ± 35.6 | |||
TV Doubling time - Recurrence (days) | ~ | 4.7 ± 2.1 | 3.6 ± 0.8 | 6.4 ± 3.4 | 4.5 ± 1.2 | |||
VVD - Recurrence (%) | ~ | 26.6 ± 73.6 | -13.4 ± 68.0 | 100.7 ± 71.0 | 19.0 ± 22.5 |
(Corrected) Table 3:
Table 3.
Dose (Gy) | Average Initial TV (mm3) (*p<0.05) |
Average Initial VVD (*p<0.05) |
||
---|---|---|---|---|
Local Failure | Local Control | Local Failure | Local Control | |
15 | 171 ± 52 | 108 ± 40 | 0.32 ± .05 | 0.37 ± 0.11 |
20 | 230 ± 67 | 137 ± 110 | 0.14 ± 0.03 | 0.14 ± 0.02 |
25 | 290 ± 77 | 169 ± 39* | 0.49 ± 0.14 | 0.47 ± 0.10 |
Discussion
Our previous paper stated significant differences in volumetric vascular density (VVD) between local control and local failure tumors in all three radiation dose cohorts (15, 20, and 25 Gy). After correcting the analysis error, significant results were found for the 20 Gy cohort, but results for the 15 and 25 Gy results are no longer significant and are inconclusive. There was no significant difference in the time of tumor volume (TV) recurrence compared to VVD recurrence in the 20 Gy group. The average trends for the local failure and local control groups in the 15 and 25 Gy cohorts appear to follow the three response phases after RT (Table 2) until tumors reach a volume of ~100 mm3, at which point VVD is observed to decrease. This is likely due to a combination of increased tumor hypoxia and loss of contrast sensitivity outside the imaging field of view. Additionally, no correlation was found between initial TV values and initial VVD values in local failure tumors. An average increase in VVD was observed in two of the four 20 Gy untreated control tumors, however this was not observed in the 15 or 25 Gy cohorts, which may also be attributed to increased tumor necrosis and hypoxia due to the fast tumor growth rates.
References
- 1.Kasoji SK, Rivera JN, Gessner RC, Chang SX, Dayton PA. Early Assessment of Tumor Response to Radiation Therapy using High-Resolution Quantitative Microvascular Ultrasound Imaging. Theranostics. 2018;8(1):156–168. doi: 10.7150/thno.19703. doi:10.7150/thno.19703. [DOI] [PMC free article] [PubMed] [Google Scholar]